Saleiro D, Platanias L
Semin Immunol. 2019; 43:101299.
PMID: 31771762
PMC: 8177745.
DOI: 10.1016/j.smim.2019.101299.
Ben-Efraim S
Mediators Inflamm. 1997; 6(3):163-73.
PMID: 18472817
PMC: 2365830.
DOI: 10.1080/09629359791659.
Jones D, Bleehen N, Slater A, George P, Walker J, Dixon A
Br J Cancer. 1983; 47(3):361-6.
PMID: 6299317
PMC: 2011299.
DOI: 10.1038/bjc.1983.54.
Heremans H, De Ley M, Billiau A
Arch Virol. 1980; 63(3-4):317-20.
PMID: 6243928
DOI: 10.1007/BF01315039.
Rodriguez M, Montano J, Williams R
Clin Exp Immunol. 1984; 55(2):369-76.
PMID: 6230183
PMC: 1535830.
Clinical and immunological studies of human fibroblast interferon.
Ezaki K, Ogawa M, Okabe K, Abe K, Inoue K, Horikoshi N
Cancer Chemother Pharmacol. 1982; 8(1):47-55.
PMID: 6178525
DOI: 10.1007/BF00292871.
Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon.
Herberman R, Ortaldo J, Rubinstein M, Pestka S
J Clin Immunol. 1981; 1(3):149-53.
PMID: 6174540
DOI: 10.1007/BF00922756.
Kinetics of human immune interferon production and blastogenesis.
Ng W, Ng M, Inoue M, Tan Y
Clin Exp Immunol. 1981; 44(3):594-602.
PMID: 6173152
PMC: 1537327.
Interferon production by a human lymphoblastoid cell line (DG-75) free of the Epstein-Barr genome.
Lazar A, Reuveny S, Minai M, Traub A, Mizrahi A
Antimicrob Agents Chemother. 1981; 20(2):151-4.
PMID: 6169305
PMC: 181655.
DOI: 10.1128/AAC.20.2.151.
Effect of interferon in therapy of skin and head and neck tumors.
PADOVAN I, Brodarec I, ikic D, Knezevic M, SOOS E
J Cancer Res Clin Oncol. 1981; 100(3):295-310.
PMID: 6168641
DOI: 10.1007/BF00410690.
Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
Rubin B, Gupta S
Proc Natl Acad Sci U S A. 1980; 77(10):5928-32.
PMID: 6160587
PMC: 350185.
DOI: 10.1073/pnas.77.10.5928.
Does interferon cure cancer?.
Sikora K
Br Med J. 1980; 281(6244):855-8.
PMID: 6159047
PMC: 1714259.
DOI: 10.1136/bmj.281.6244.855.
Interferons, a group of multiple lymphokines.
Kirchner H
Springer Semin Immunopathol. 1984; 7(4):347-74.
PMID: 6084313
DOI: 10.1007/BF00201966.
[Interferons--research, effects and importance].
Lodemann E
Naturwissenschaften. 1984; 71(11):547-51.
PMID: 6084176
DOI: 10.1007/BF01189177.
Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon.
Ohno R, Kodera Y, Ogura M, Murase T, Emi N, Okumura M
Cancer Chemother Pharmacol. 1985; 14(1):34-7.
PMID: 3917376
DOI: 10.1007/BF00552722.
The potential of interferons in malignant disease.
Okita K, Kaneko T
Drugs. 1990; 39(1):1-6.
PMID: 1690107
DOI: 10.2165/00003495-199039010-00001.
Electrophoretically pure mouse interferon exerts multiple biologic effects.
GRESSER I, De Maeyer-Guignard J, Tovey M, De Maeyer E
Proc Natl Acad Sci U S A. 1979; 76(10):5308-12.
PMID: 291948
PMC: 413131.
DOI: 10.1073/pnas.76.10.5308.
Intramuscular and/or intralumbar postexposure treatment of rabies virus-infected cynomolgus monkeys with human interferon.
Weinmann E, Majer M, Hilfenhaus J
Infect Immun. 1979; 24(1):24-31.
PMID: 110693
PMC: 414256.
DOI: 10.1128/iai.24.1.24-31.1979.
Antiviral agents: action and clinical use.
Chang T, Snydman D
Drugs. 1979; 18(5):354-76.
PMID: 92398
DOI: 10.2165/00003495-197918050-00002.